Data extraction The generic and brand names of GLP-1 RAs approved by the FDA were used to identify adverse events of GLP-1 RAs in the DRUG files, including exenatide (BYETTA, BYDUREON), liraglutide (VICTOZA, SAXENDA), dulaglutide (TRULICITY), lixisenatide (ADLYXIN, SOLIQUA), and semaglutide (OZEMPIC, RYBELSUS, WEGOVY)
These shifts in glutamate pools could be achieved without increasing oxidative stress or cell death
Youll need to consider factors like how much breast milk is baby getting, whether its primary nutrition or supplemental, and whether you could switch to formula
This stack suits recovery-focused protocols, particularly for connective tissue injuries or periods of high training stress